The six MDGs (ABCG1, HAVCR2, CD14, TGFA, KDF1, and KITLG) we identified in this study were significantly associated with ccRCC patient outcomes and therefore may play an important role in disease progression. Here, HAVCR2 is linked to nonpapillary renal cell carcinoma.